Cryptotanshinone attenuates isoprenaline-induced cardiac fibrosis in mice associated with upregulation and activation of matrix metalloproteinase-2

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 145-150

  Ma, Shuangtao ^a   Yang, Dachun ^a   Wang, Kuiying ^a   Tang, Bing ^a   Li, De ^a   Yang, Yongjian ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Cardiac fibrosis; Cryptotanshinone; Matrix metalloproteinase 2

Indexed keywords

CRYPTOTANSHINONE; GELATINASE A; ISOPRENALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; HEART MUSCLE FIBROSIS; MALE; MOUSE; NONHUMAN; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; DRUGS, CHINESE HERBAL; ENZYME ACTIVATION; FIBROSIS; HEART VENTRICLES; HEMODYNAMICS; ISOPROTERENOL; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOFIBROBLASTS; PHENANTHRENES; UP-REGULATION;

MUS; SALVIA MILTIORRHIZA;

EID: 84861651890     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.866     Document Type: Article

References (28)

1. Vasan RS and Benjamin EJ: Diastolic heart failure - no time to relax. N Engl J Med 344: 56-59, 2001.
2. Weber KT, Brilla CG and Janicki JS: Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27: 341-348, 1993. (Pubitemid 23116130)
3. Yamamoto K, Masuyama T, Sakata Y, et al: Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 55: 76-82, 2002. (Pubitemid 34615941)
4. Yamamoto K, Takahashi Y, Mano T, et al: N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism. Eur Heart J 25: 1221-1229, 2004. (Pubitemid 38891572)
5. Zeisberg EM, Tarnavski O, Zeisberg M, et al: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007. (Pubitemid 47222040)
6. Janicki JS, Brower GL, Henegar JR and Wang L: Ventricular remodeling in heart failure: the role of myocardial collagen. Adv Exp Med Biol 382: 239-245, 1995.
7. Spinale FG: Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90: 520-530, 2002.
8. Li YY, McTiernan CF and Feldman AM: Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46: 214-224, 2000. (Pubitemid 30204593)
9. Van Linthout S, Seeland U, Riad A, et al: Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103: 319-327, 2008.
10. Lupia E, Elliot SJ, Lenz O, et al: IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 48: 1638-1644, 1999. (Pubitemid 29356874)
11. Lee RT: Matrix metalloproteinase inhibition and the prevention of heart failure. Trends Cardiovasc Med 11: 202-205, 2001.
12. Ling S, Dai A, Guo Z and Komesaroff PA: A preparation of herbal medicine Salvia miltiorrhiza reduces expression of intercellular adhesion molecule-1 and development of atherosclerosis in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 51: 38-44, 2008.
13. Lei XL and Chiou GC: Studies on cardiovascular actions of Salvia miltiorrhiza. Am J Chin Med 14: 26-32, 1986.
14. Maki T, Kawahara Y, Tanonaka K, Yagi A and Takeo S: Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats. Planta Med 68: 1103-1107, 2002. (Pubitemid 36140316)
15. Yang L, Zou XJ, Gao X, et al: Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro. Exp Mol Med 41: 508-516, 2009.
16. Lee DS, Lee SH, Noh JG and Hong SD: Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge. Biosci Biotechnol Biochem 63: 2236-2239, 1999.
17. Chiou WF and Don MJ: Cryptotanshinone inhibits macrophage migration by impeding F-actin polymerization and filopodia extension. Life Sci 81: 109-114, 2007.
18. Mei Z, Zhang F, Tao L, et al: Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neurosci Lett 452: 90-95, 2009.
19. Stempien-Otero A, Plawman A, Meznarich J, Dyamenahalli T, Otsuka G and Dichek DA: Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator. J Biol Chem 281: 15345-15351, 2006. (Pubitemid 43855125)
20. Kacimi R, Vessey DA, Honbo N and Karliner JS: Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response. J Mol Cell Cardiol 43: 85-91, 2007. (Pubitemid 46898421)
21. Yang D, Ma S, Li D, Tang B and Yang Y: Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium. Biochem Biophys Res Commun 388: 606-611, 2009.
22. Riches K, Morley ME, Turner NA, et al: Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. J Mol Cell Cardiol 47: 391-399, 2009.
23. Aimes RT and Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270: 5872-5876, 1995.
24. Han SY, Jee YH, Han KH, et al: An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dial Transplant 21: 2406-2416, 2006. (Pubitemid 44644511)
25. Bergman MR, Teerlink JR, Mahimkar R, et al: Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol 292: H1847-1860, 2007. (Pubitemid 46572408)
26. Matsusaka H, Ide T, Matsushima S, et al: Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension 47: 711-717, 2006. (Pubitemid 43740243)
27. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK and Leehey DJ: High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol 9: 249-257, 2001. (Pubitemid 32620209)
28. Jin YC, Kim CW, Kim YM, et al: Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur J Pharmacol 614: 91-97, 2009.